KR101949210B1 - 항염증 활성을 가진 인간 락토페린계 펩타이드 - Google Patents

항염증 활성을 가진 인간 락토페린계 펩타이드 Download PDF

Info

Publication number
KR101949210B1
KR101949210B1 KR1020137021855A KR20137021855A KR101949210B1 KR 101949210 B1 KR101949210 B1 KR 101949210B1 KR 1020137021855 A KR1020137021855 A KR 1020137021855A KR 20137021855 A KR20137021855 A KR 20137021855A KR 101949210 B1 KR101949210 B1 KR 101949210B1
Authority
KR
South Korea
Prior art keywords
arg
seq
peptide
lys
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020137021855A
Other languages
English (en)
Korean (ko)
Other versions
KR20140026367A (ko
Inventor
마지트 말라푸
까밀라 비요른
베로니카 스예스트란드
베른 왈스
보 스벤슨
Original Assignee
페르가뭄 아베
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 페르가뭄 아베 filed Critical 페르가뭄 아베
Publication of KR20140026367A publication Critical patent/KR20140026367A/ko
Application granted granted Critical
Publication of KR101949210B1 publication Critical patent/KR101949210B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
KR1020137021855A 2011-01-26 2012-01-25 항염증 활성을 가진 인간 락토페린계 펩타이드 Expired - Fee Related KR101949210B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11152213A EP2481751A1 (en) 2011-01-26 2011-01-26 Human lactoferrin derived peptides
EP11152213.2 2011-01-26
PCT/EP2012/051111 WO2012101156A2 (en) 2011-01-26 2012-01-25 New synthetic peptides and their use

Publications (2)

Publication Number Publication Date
KR20140026367A KR20140026367A (ko) 2014-03-05
KR101949210B1 true KR101949210B1 (ko) 2019-02-18

Family

ID=44123487

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020137021855A Expired - Fee Related KR101949210B1 (ko) 2011-01-26 2012-01-25 항염증 활성을 가진 인간 락토페린계 펩타이드
KR1020137021856A Expired - Fee Related KR101933900B1 (ko) 2011-01-26 2012-01-25 인간 락토페린 유래 펩타이드 및 이의 용도

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020137021856A Expired - Fee Related KR101933900B1 (ko) 2011-01-26 2012-01-25 인간 락토페린 유래 펩타이드 및 이의 용도

Country Status (13)

Country Link
US (2) US9132165B2 (https=)
EP (3) EP2481751A1 (https=)
JP (2) JP6158712B2 (https=)
KR (2) KR101949210B1 (https=)
CN (2) CN103476792B (https=)
AU (2) AU2012210564B2 (https=)
BR (2) BR112013018365A2 (https=)
CA (2) CA2825246A1 (https=)
ES (2) ES2645959T3 (https=)
MX (2) MX341020B (https=)
PL (1) PL2668205T3 (https=)
RU (2) RU2593757C2 (https=)
WO (2) WO2012101156A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2481751A1 (en) * 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
GB201401877D0 (en) * 2014-02-04 2014-03-19 Univ Tromsoe Peptides
CN104888202A (zh) * 2014-05-22 2015-09-09 闫牧乔 一种治疗扁桃体炎的药物
IT201800002457A1 (it) * 2018-02-07 2019-08-07 Neilos S R L Composizione per la prevenzione e il trattamento delle affezioni delle vie respiratorie
RU2681216C1 (ru) * 2018-09-05 2019-03-05 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ стимуляции регенерации инфицированных ран кожи и мягких тканей с применением пептида Gly-His-Lys-D-Ala
RU2681310C1 (ru) * 2018-09-05 2019-03-06 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ первичной хирургической обработки инфицированных ран кожи и мягких тканей с использованием пептида Gly-His-Lys-D-Ala
WO2020096672A1 (en) 2018-11-09 2020-05-14 The Wistar Institute Of Anatomy And Biology Use of lactoferrin for generating myeloid-derived suppressor cells
KR102032945B1 (ko) * 2018-12-03 2019-10-16 순천대학교 산학협력단 항염증 활성을 나타내는 펩타이드 및 이를 유효성분으로 포함하는 항염증용 조성물
NL2024839B1 (en) * 2020-02-05 2021-09-13 Cbmr Scient Nanoscience B V Antimicrobial peptide for treatment and controlling skin disorders relating to microbial infection

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002100387A1 (en) 2001-06-11 2002-12-19 A+ Science Invest Ab Prevention of neovascularization of intervertebral discs and/or of tissues with local inflammation
WO2010081800A2 (en) * 2009-01-13 2010-07-22 Pharmasurgics In Sweden Ab New pharmaceutical compositions

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2818056B2 (ja) 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
EP0629347B1 (en) 1992-01-23 1997-07-02 Morinaga Milk Industry Co., Ltd. Antibacterial agent and treatment of article therewith
JP3347819B2 (ja) 1993-06-28 2002-11-20 森永乳業株式会社 抗菌性ペプチドの精製方法
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
JP3529423B2 (ja) 1994-04-01 2004-05-24 森永乳業株式会社 抗菌性ペプチドの製造方法
JP3812957B2 (ja) 1994-08-02 2006-08-23 森永乳業株式会社 角膜損傷治療剤
JPH08143468A (ja) 1994-11-17 1996-06-04 Morinaga Milk Ind Co Ltd 抗潰瘍剤
WO1998006425A1 (en) 1996-08-12 1998-02-19 A+ Science Invest Ab Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
US6696545B1 (en) * 1997-04-11 2004-02-24 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
SE9804614A0 (en) * 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
MXPA01011606A (es) * 1999-05-14 2003-09-10 Univ California Terapia anti-inflamatoria para infeccion mediada por inflamacion.
JP2003521483A (ja) 1999-11-11 2003-07-15 エイエム ファーマ ビーブイ ヒトラクトフェリンの第１カチオンクラスターの抗菌活性
RU2165769C1 (ru) * 2000-07-13 2001-04-27 Якубовская Раиса Ивановна Антибактериальный, антиоксидантный, иммуномодулирующий и антиканцерогенный препарат и способ его применения
WO2006047744A2 (en) 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof
AU2007272272B2 (en) * 2006-07-10 2012-04-12 Pba3 Biomed Gmbh Antimicrobial peptides
WO2008096816A1 (ja) * 2007-02-09 2008-08-14 Genomidea Inc. 血管新生誘導剤及びそれに用いられるポリペプチド
WO2008096814A1 (ja) * 2007-02-09 2008-08-14 Genomidea Inc. 新規ポリペプチド及びそれを有効成分として含有する抗菌剤
EP2050461A1 (en) 2007-10-19 2009-04-22 PharmaSurgics in Sweden AB Peptides based on the sequence of human lactoferrin and their use
EP2060586A1 (en) * 2007-11-14 2009-05-20 PharmaSurgics in Sweden AB New synthetic arginine substituted peptides and their use
KR101350251B1 (ko) * 2008-05-23 2014-01-14 다이이찌 산쿄 가부시키가이샤 목적 펩타이드의 혈장내 반감기 연장 작용을 가진 펩타이드
EP2481751A1 (en) * 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
KR101341210B1 (ko) * 2013-01-24 2013-12-12 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 신규한 항균 펩타이드 및 이의 용도

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002100387A1 (en) 2001-06-11 2002-12-19 A+ Science Invest Ab Prevention of neovascularization of intervertebral discs and/or of tissues with local inflammation
WO2010081800A2 (en) * 2009-01-13 2010-07-22 Pharmasurgics In Sweden Ab New pharmaceutical compositions

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Molecular Immunology, Vol. 44, pp. 1498-1508 (2006.10.09.)
Peptides, Vol. 31, pp. 1251-1261 (온라인 공개일: 2010.04.02.)*
Scandinavian Journal of Immunology, Vol. 57, pp. 2-10 (2003.)

Also Published As

Publication number Publication date
RU2596393C2 (ru) 2016-09-10
US20140031296A1 (en) 2014-01-30
EP2668205B1 (en) 2017-05-10
WO2012101156A2 (en) 2012-08-02
RU2013139294A (ru) 2015-03-10
RU2593757C2 (ru) 2016-08-10
BR112013018264A2 (pt) 2016-08-30
US8846608B2 (en) 2014-09-30
MX342313B (es) 2016-09-26
CN103476792B (zh) 2015-11-25
CN103459419A (zh) 2013-12-18
EP2668204A2 (en) 2013-12-04
MX2013007995A (es) 2013-12-02
US20130310306A1 (en) 2013-11-21
EP2481751A1 (en) 2012-08-01
AU2012210565B2 (en) 2017-03-30
MX2013008530A (es) 2013-12-09
RU2013139302A (ru) 2015-03-10
KR20140026367A (ko) 2014-03-05
CN103476792A (zh) 2013-12-25
JP2014505061A (ja) 2014-02-27
AU2012210564B2 (en) 2016-10-27
EP2668205A1 (en) 2013-12-04
WO2012101157A1 (en) 2012-08-02
ES2633353T3 (es) 2017-09-20
US9132165B2 (en) 2015-09-15
JP6158712B2 (ja) 2017-07-05
CN103459419B (zh) 2016-05-11
KR20140020252A (ko) 2014-02-18
CA2825246A1 (en) 2012-08-02
EP2668204B1 (en) 2017-09-27
ES2645959T3 (es) 2017-12-11
JP6158713B2 (ja) 2017-07-05
KR101933900B1 (ko) 2018-12-31
JP2014505062A (ja) 2014-02-27
WO2012101156A3 (en) 2013-05-30
MX341020B (es) 2016-08-04
CA2825247A1 (en) 2012-08-02
PL2668205T3 (pl) 2017-09-29
BR112013018365A2 (pt) 2016-08-30

Similar Documents

Publication Publication Date Title
KR101949210B1 (ko) 항염증 활성을 가진 인간 락토페린계 펩타이드
AU2012210564A1 (en) Human lactoferrin based peptides having antiinflammatory activity
AU2012210565A1 (en) Human lactoferrin derived peptides and there use
RU2660351C2 (ru) Антимикробные пептиды
EP1966235A2 (en) Antimicrobial cathelicidin peptides
US8815812B2 (en) Synthetic arginine substituted peptides and their use
HK1149769A (en) New synthetic arginine substituted peptides and their use

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R15-X000 Change to inventor requested

St.27 status event code: A-3-3-R10-R15-oth-X000

R16-X000 Change to inventor recorded

St.27 status event code: A-3-3-R10-R16-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R17-X000 Change to representative recorded

St.27 status event code: A-5-5-R10-R17-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20230213

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20230213